Stock MSTY1 MAINSTAY MEDICAL INTERNATIONAL
Add to a list
To use this feature you must be a member
Log inSign up

Financials Mainstay Medical International Irish S.E.

Equities

MSTY1

IE00BJYS1G50

Advanced Medical Equipment & Technology

Delayed Irish S.E.
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Mainstay Medical International +6.44% -38.57%
Mar. 12 Mainstay Medical Holdings plc Announces Publication of Clinical Results Comparing Older Patients and Younger Patients CI
Feb. 26 Mainstay Medical Holdings plc announced that it has received ?115 million in funding from a group of investors CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 122.9 58.32 51.12 29.71 29.71 29.71
Enterprise Value (EV) 1 127.3 54.73 51.46 47.51 -24.45 132.2
P/E ratio -4.12 x -1.82 x -1.83 x -1.58 x -0.85 x -0.61 x
Yield - - - - - -
Capitalization / Revenue 353 x 88 x 46.3 x 19.8 x 5.58 x 2.93 x
EV / Revenue 366 x 82.5 x 46.6 x 31.7 x -4.59 x 13 x
EV / EBITDA -4.61 x -1.87 x -2.76 x -2.82 x 0.77 x -3.11 x
EV / FCF -9 x -3.35 x -5.95 x -4.5 x 1.21 x -4.42 x
FCF Yield -11.1% -29.9% -16.8% -22.2% 82.5% -22.6%
Price to Book -21.1 x 17.8 x 1,550 x -1.66 x 0.51 x -0.32 x
Nbr of stocks (in thousands) 6,619 8,770 13,422 13,439 13,439 13,439
Reference price 2 18.57 6.650 3.809 2.210 2.210 2.210
Announcement Date 2/15/18 4/18/19 2/25/20 7/9/21 3/28/22 3/28/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.348 0.663 1.105 1.497 5.327 10.13
EBITDA 1 -27.61 -29.2 -18.68 -16.86 -31.66 -42.54
EBIT 1 -27.72 -29.28 -18.79 -16.91 -31.81 -42.96
Operating Margin -7,965.23% -4,417.04% -1,700.45% -1,129.53% -597.15% -424.03%
Earnings before Tax (EBT) 1 -29.6 -31.18 -22.26 -18.82 -34.59 -48.53
Net income 1 -29.84 -31.08 -22.38 -18.88 -35.18 -49.13
Net margin -8,573.28% -4,687.33% -2,025.79% -1,261.12% -660.43% -484.97%
EPS 2 -4.510 -3.654 -2.081 -1.402 -2.612 -3.648
Free Cash Flow 1 -14.15 -16.35 -8.651 -10.55 -20.17 -29.91
FCF margin -4,066.2% -2,466.12% -782.93% -704.86% -378.64% -295.22%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/15/18 4/18/19 2/25/20 7/9/21 3/28/22 3/28/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 4.42 - 0.34 17.8 - 102
Net Cash position 1 - 3.6 - - 54.2 -
Leverage (Debt/EBITDA) -0.1599 x - -0.0183 x -1.056 x - -2.409 x
Free Cash Flow 1 -14.2 -16.4 -8.65 -10.6 -20.2 -29.9
ROE (net income / shareholders' equity) -392% 2,450% -1,350% 211% -172% 68.3%
ROA (Net income/ Total Assets) -66.1% -112% -58.7% -68.4% -40.5% -37.3%
Assets 1 45.11 27.78 38.16 27.6 86.88 131.7
Book Value Per Share 2 -0.8800 0.3700 0 -1.330 4.350 -7.010
Cash Flow per Share 2 1.510 1.770 1.300 0.4700 5.680 3.110
Capex 1 0.05 0.12 0.01 0.11 0.66 1.3
Capex / Sales 15.23% 18.55% 0.45% 7.28% 12.43% 12.83%
Announcement Date 2/15/18 4/18/19 2/25/20 7/9/21 3/28/22 3/28/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. MSTY Stock
  4. MSTY1 Stock
  5. Financials Mainstay Medical International